BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25735349)

  • 1. Malignant transformation rate and p53, and p16 expression in teratomatous skin of ovarian mature cystic teratoma.
    Zhu HL; Zou ZN; Lin PX; Li WX; Huang YE; Shi XX; Shen H
    Asian Pac J Cancer Prev; 2015; 16(3):1165-8. PubMed ID: 25735349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins.
    Iwasa A; Oda Y; Kurihara S; Ohishi Y; Yasunaga M; Nishimura I; Takagi E; Kobayashi H; Wake N; Tsuneyoshi M
    Pathol Int; 2008 Dec; 58(12):757-64. PubMed ID: 19067849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Frequency of Malignant Transformation of Ovarian Mature Teratoma into Squamous Cell Carcinoma in Young Patients in Northeast Brazil.
    Araujo IB; Pinheiro MV; Zanvettor PH; Studart EJ; Filho DF; Coupland SE
    Int J Gynecol Pathol; 2016 Mar; 35(2):176-84. PubMed ID: 26367783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant Transformation of Mature Cystic Teratoma: Is Squamous Cell Carcinoma Different From the Other Types of Neoplasm?
    Akazawa M; Onjo S
    Int J Gynecol Cancer; 2018 Nov; 28(9):1650-1656. PubMed ID: 30358706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclooxygenase-2 in ovarian mature cystic teratomas with malignant transformation.
    Sumi T; Ishiko O; Yoshida H; Hyun Y; Nakagawa E; Hirai K; Matsumoto Y; Ogita S
    Int J Mol Med; 2001 Nov; 8(5):495-8. PubMed ID: 11605016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and molecular studies on malignant transformation in mature cystic teratoma of the ovary.
    Yoshioka T; Tanaka T
    J Obstet Gynaecol Res; 1998 Apr; 24(2):83-90. PubMed ID: 9631595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of 44 cases with malignant transformation of ovarian mature cystic teratoma].
    An JS; Wu LY; Li XG; Zhang R; Song Y; Ma SK; Liu LY; Hong WJ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):123-8. PubMed ID: 23544494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mature cystic ovarian teratoma with squamous cell carcinoma transformation: a case report and literature review.
    Abdoli Shadbad M; Derogar R; Shekarchi AA; Akbari F; Jafari Shobeiri M
    Horm Mol Biol Clin Investig; 2024 Mar; 45(1):35-39. PubMed ID: 38282269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution.
    Oranratanaphan S; Khemapech N
    Asian Pac J Cancer Prev; 2013; 14(8):4693-7. PubMed ID: 24083728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53, p16 and Ki67 immunoexpression in cutaneous squamous cell carcinoma and its precursor lesions.
    Marinescu A; Stepan AE; Mărgăritescu C; Marinescu AM; Zăvoi RE; Simionescu CE; Niculescu M
    Rom J Morphol Embryol; 2016; 57(2 Suppl):691-696. PubMed ID: 27833960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma and pleomorphic sarcoma (MFH) arising in a mature cystic teratoma of the ovary.
    Savitchi E; Rao S
    Int J Gynecol Pathol; 2012 Sep; 31(5):443-6. PubMed ID: 22833084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
    Lu DW; El-Mofty SK; Wang HL
    Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Squamous cell carcinoma in situ arising in ovarian mature cystic teratoma].
    Gurrera A; Brancato F; Puzzo L; Magro G; Greco P
    Pathologica; 2008 Feb; 100(1):9-12. PubMed ID: 18686519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
    Cai S; Han K
    J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
    Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
    J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma arising in mature cystic teratoma with sigmoid invasion.
    Srivastava P; Dawson L; Mandal AK
    J Cancer Res Ther; 2015; 11(4):1024. PubMed ID: 26881587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation from mature cystic teratoma of the ovary.
    Shimada T; Higashijima A; Fukushima A; Komatsu N; Noguchi M; Ohashi K; Hasegawa Y; Miura K
    J Obstet Gynaecol Res; 2019 Sep; 45(9):1957-1960. PubMed ID: 31215124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A challenging question for gynecologic oncologists.
    Gadducci A; Guerrieri ME; Cosio S
    Crit Rev Oncol Hematol; 2019 Jan; 133():92-98. PubMed ID: 30661663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Transformation in Mature Cystic Teratomas of the Ovary: Case Reports and Review of the Literature.
    Gadducci A; Pistolesi S; Guerrieri ME; Cosio S; Carbone FG; Naccarato AG
    Anticancer Res; 2018 Jun; 38(6):3669-3675. PubMed ID: 29848726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.